Cognizant Technology Solutions
CTSH
$55.35
+2.70%
Cognizant Technology Solutions is a multinational IT services and consulting company that provides digital transformation, technology services, and business process outsourcing to enterprise clients. As a leading player in the global IT services industry, Cognizant differentiates itself through its global delivery model, with a significant offshore workforce in India, serving key verticals such as financial services, healthcare, and communications. The current investor narrative centers on the company's growth trajectory amid a challenging macroeconomic environment, with recent focus on its ability to sustain revenue growth and margin expansion while navigating competitive pressures and evolving client demand for AI and cloud services.…
CTSH
Cognizant Technology Solutions
$55.35
CTSH 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Cognizant Technology Solutions's 12-month outlook, with a consensus price target around $63.10 and implied upside of +14.0% versus the current price.
Average Target
$63.10
0 analysts
Implied Upside
+14.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$42 - $84
Analyst target range
Cognizant is covered by 25 analysts, with a consensus recommendation of 'Buy' and a mean recommendation score of 2.17 (where 1 is Strong Buy and 5 is Sell). The average target price is $60.98, implying approximately 34% upside from the current price of $45.45. The distribution of ratings is not provided, but the consensus leans bullish. The target price range spans from a low of $42.00 to a high of $88.00. The high target of $88.00 assumes a significant recovery in growth and margins, potentially driven by AI adoption and cost optimization. The low target of $42.00 suggests downside risk if the company fails to stabilize margins or faces demand headwinds. The wide spread between low and high targets indicates high uncertainty about the company's future performance. Recent ratings actions show a mix of neutral and positive stances, with Wedbush upgrading to Outperform in June 2026, while most other firms maintain Neutral or Hold ratings. The lack of strong bullish conviction from many analysts suggests that while the stock is seen as undervalued, catalysts for a re-rating are not yet evident.
Drowning in data?
Find the real signal!
Bulls vs Bears: CTSH Investment Factors
Cognizant presents a classic value trap debate: strong fundamentals (low debt, high cash flow, analyst upside) versus severe technical weakness and margin erosion. The bull case rests on the forward P/E of 7.3x implying a sharp earnings recovery, while the bear case highlights decelerating growth and contracting margins. Currently, the bearish evidence is more compelling given the 40.8% annual decline and lack of catalysts to reverse the downtrend. The single most important tension is whether the company can stabilize margins and re-accelerate growth, which would validate the low forward multiple and drive a re-rating.
Bullish
- Strong Balance Sheet and Cash Flow: Cognizant has a debt-to-equity ratio of only 0.10 and a current ratio of 2.34, indicating minimal leverage and ample liquidity. Trailing twelve-month free cash flow is $2.47 billion, providing a solid foundation for dividends and buybacks.
- Analyst Consensus Buy with 34% Upside: The average analyst target price is $60.98, implying approximately 34% upside from the current price of $45.45. The consensus recommendation is Buy with a mean score of 2.17, suggesting broad optimism among analysts.
- Low Forward P/E Suggests Undervaluation: The forward P/E ratio of 7.3x is near the low end of its historical range and well below the trailing P/E of 18.2x, implying the market expects a significant earnings recovery. This could present a value opportunity if earnings materialize.
- Resilient Revenue Growth in Key Verticals: Q1 2026 revenue grew 5.8% YoY to $5.413 billion, driven by Financial Services ($1.644B) and Healthcare ($1.579B). Despite macro headwinds, the company continues to grow, supported by digital transformation demand.
Bearish
- Severe Price Decline and Technical Weakness: The stock has declined 40.8% over the past year, significantly underperforming the S&P 500's 16.5% gain. It trades near the bottom of its 52-week range, with a maximum drawdown of -55.3%, indicating persistent selling pressure.
- Margin Compression Threatens Profitability: Gross margin fell from 33.6% in Q2 2025 to 29.6% in Q1 2026, while operating margin declined from 16.7% to 15.1% over the same period. This compression suggests rising costs and competitive pricing pressure.
- Decelerating Revenue Growth Trajectory: Revenue growth has decelerated from 7.3% YoY in Q3 2025 to 5.8% in Q1 2026. If this trend continues, it could lead to further multiple compression and analyst downgrades.
- High Valuation Premium on Trailing P/E: The trailing P/E of 18.2x is at a 21% premium to the industry median of 15x. Given margin compression and growth deceleration, this premium may be unjustified, leaving room for de-rating.
CTSH Technical Analysis
CTSH is in a sustained downtrend, with the stock price declining 40.8% over the past year. The current price of $45.45 is near the bottom of its 52-week range, trading at approximately 52% of the 52-week high of $87.03 and 23% above the 52-week low of $37.08. This positioning near the low end suggests the stock is deeply oversold and potentially offering a value opportunity, but it also reflects persistent selling pressure and a lack of bullish momentum. The 1-year price change of -40.8% significantly underperforms the S&P 500's gain of 16.5%, indicating severe relative weakness. Short-term momentum shows a mixed picture: the 1-month price change is +9.7%, suggesting a recent bounce, but the 3-month change is -17.5%, indicating that the longer-term downtrend remains intact. The divergence between the positive 1-month return and the negative 3-month and 1-year returns could signal a potential short-term reversal or a temporary relief rally within a broader bear market. The stock's beta of 0.86 implies it is less volatile than the market, but the recent price action has been highly volatile, with a maximum drawdown of -55.3% over the period. Key support is at the 52-week low of $37.08; a breakdown below this level would signal further downside and a potential test of lower support. Resistance is at the 52-week high of $87.03, but more immediate resistance is near the $50 level, which acted as support in May 2026. A breakout above $50 could signal a trend reversal, but the stock remains in a downtrend until it can reclaim higher levels.
Beta
0.86
0.86x market volatility
Max Drawdown
-55.3%
Largest decline past year
52-Week Range
$37-$87
Price range past year
Annual Return
-22.9%
Cumulative gain past year
| Period | CTSH Return | S&P 500 |
|---|---|---|
| 1m | +34.8% | +0.2% |
| 3m | +5.6% | +3.7% |
| 6m | -32.5% | +8.0% |
| 1y | -22.9% | +18.2% |
| ytd | -31.9% | +9.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CTSH Fundamental Analysis
Cognizant's revenue trajectory shows moderate growth, with Q1 2026 revenue of $5.413 billion, up 5.8% year-over-year. However, growth has been decelerating from the 6.5% YoY growth in Q4 2025 and 7.3% in Q3 2025. Revenue by segment shows Financial Services ($1.644B) and Healthcare ($1.579B) as the largest contributors, while Communication, Media and Technology ($0.869B) and Products and Resources ($1.321B) are smaller. The growth is being driven by digital services and cloud, but the deceleration raises concerns about demand in a softening IT spending environment. The company is profitable, with Q1 2026 net income of $662 million and a net margin of 12.2%. Gross margin was 29.6% in Q1 2026, down from 33.6% in Q2 2025, indicating margin compression due to higher cost of revenue. Operating margin was 15.1% in Q1 2026, down from 16.7% in Q1 2025, suggesting pressure from wage inflation and investments. The trend is concerning as margins are contracting despite revenue growth, and the company needs to demonstrate cost discipline to protect profitability. Cognizant has a strong balance sheet with a debt-to-equity ratio of 0.10 and a current ratio of 2.34, indicating ample liquidity. Free cash flow for the trailing twelve months is $2.47 billion, providing a solid cash generation capability. The company generated $274 million in operating cash flow in Q1 2026, but capital expenditures were only $76 million, resulting in free cash flow of $198 million. ROE is 14.9%, which is healthy, and the company has been returning cash to shareholders through dividends and buybacks, with $159 million in dividends paid and $444 million in stock repurchases in Q1 2026. The strong cash flow and low debt levels provide financial flexibility for investments and shareholder returns.
Quarterly Revenue
$5.4B
2026-03
Revenue YoY Growth
+5.8%
YoY Comparison
Gross Margin
29.6%
Latest Quarter
Free Cash Flow
$2.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CTSH Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 18.2x, while the forward P/E is 7.3x, implying a significant earnings growth expectation. The large gap between trailing and forward P/E suggests the market expects a sharp earnings recovery, which may be overly optimistic given the current margin pressures. Compared to the industry average (Information Technology Services), the trailing P/E of 18.2x is at a premium to the sector median of approximately 15x, indicating a 21% premium. This premium may be justified by Cognizant's strong market position and cash flow generation, but the margin compression and growth deceleration warrant a discount. Historically, the stock's trailing P/E has ranged from 11x to 30x over the past five years. The current 18.2x is near the middle of this range, suggesting it is not extremely overvalued or undervalued relative to its own history. However, the forward P/E of 7.3x is near the low end of historical forward multiples, which could indicate that the market is pricing in a pessimistic outlook or that earnings are expected to rebound sharply. The P/S ratio of 1.89x is below the historical average of around 3x, suggesting the stock is cheap on a sales basis, but this is consistent with the margin compression.
PE
18.2x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 11x~21x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
9.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Cognizant's primary financial risk is margin compression, with gross margin falling from 33.6% to 29.6% over the past year and operating margin declining from 16.7% to 15.1%. This pressure stems from wage inflation and investments in digital capabilities, which could persist if the company cannot pass costs to clients. The debt-to-equity ratio is low at 0.10, but the reliance on revenue growth to justify the forward P/E of 7.3x means any shortfall could lead to earnings disappointment. Free cash flow of $2.47 billion provides a buffer, but the deceleration in revenue growth (from 7.3% to 5.8% YoY) raises concerns about demand sustainability.
Market & Competitive Risks: The stock's beta of 0.86 suggests lower market correlation, but its 40.8% annual decline indicates company-specific weakness. The trailing P/E of 18.2x is at a 21% premium to the industry median, making it vulnerable to multiple compression if growth disappoints. Competitive risks include pricing pressure from Indian IT peers and the need to invest in AI and cloud to stay relevant. Recent news of a tech-led market rally (Nasdaq 100) could provide a tailwind, but Cognizant's relative strength is deeply negative (-57.2% over 1 year), suggesting it is being left behind.
Worst-Case Scenario: If revenue growth continues to decelerate below 5% and margins fail to stabilize, the stock could fall to the 52-week low of $37.08, representing a downside of approximately 18.4% from the current price of $45.45. In a severe recession scenario, the stock could test lower levels, potentially revisiting the $30 range based on historical drawdowns. The analyst low target of $42.00 implies a 7.6% downside, but the worst-case could be more severe if earnings miss estimates.
